HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hung-Hsueh Chou Selected Research

Endometrial Neoplasms (Endometrial Cancer)

1/2017Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression.
10/2016Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology.
9/2014A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (MMP1) in endometrial cancer.
6/2014Treatment failure in endometrial carcinoma.
5/2014Fertility-preserving treatment in young women with endometrial adenocarcinoma: a long-term cohort study.
2/2013Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23).
6/2012Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma.
1/200618F-FDG PET in the management of endometrial cancer.
4/2002Fertility-preserving treatment in young patients with endometrial adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hung-Hsueh Chou Research Topics

Disease

27Neoplasms (Cancer)
12/2022 - 04/2002
14Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018 - 10/2003
12Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 01/2013
9Endometrial Neoplasms (Endometrial Cancer)
01/2017 - 04/2002
8Carcinoma (Carcinomatosis)
10/2021 - 04/2002
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 09/2004
5Neoplasm Metastasis (Metastasis)
10/2016 - 09/2004
4Ovarian Epithelial Carcinoma
10/2022 - 06/2006
3Adenocarcinoma
10/2012 - 04/2002
3Uterine Cervical Dysplasia
02/2011 - 04/2004
2Peritoneal Neoplasms
12/2022 - 12/2021
2Neutropenia
12/2022 - 07/2021
2Disease Progression
07/2021 - 12/2014
2Wounds and Injuries (Trauma)
01/2021 - 04/2015
2Papillomavirus Infections
01/2021 - 12/2012
2Adenosquamous Carcinoma
10/2012 - 06/2011
2Lymphatic Metastasis
06/2011 - 11/2010
1Anemia
12/2022
1Fatigue
07/2021
1Postoperative Pain
01/2021
1Thrombocytopenia (Thrombopenia)
01/2018
1Chromosomal Instability (Chromosome Stability)
10/2016
1Carcinogenesis
02/2013
1Infections
12/2012

Drug/Important Bio-Agent (IBA)

6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018 - 10/2003
3PlatinumIBA
12/2022 - 06/2006
3VaccinesIBA
01/2021 - 07/2006
3Biomarkers (Surrogate Marker)IBA
12/2014 - 01/2013
3PhosphoproteinsIBA
06/2013 - 01/2013
3DNA (Deoxyribonucleic Acid)IBA
05/2010 - 04/2004
2Bevacizumab (Avastin)FDA Link
07/2021 - 01/2017
2Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 06/2017
2Carboplatin (JM8)FDA LinkGeneric
01/2020 - 01/2018
2Cisplatin (Platino)FDA LinkGeneric
06/2017 - 06/2015
2ParaffinIBA
12/2016 - 02/2011
2Formaldehyde (Formol)FDA Link
12/2016 - 02/2011
2Phosphotransferases (Kinase)IBA
09/2014 - 01/2013
2Megestrol Acetate (Borea)FDA LinkGeneric
05/2014 - 04/2002
2AntigensIBA
06/2013 - 07/2006
2Hormones (Hormone)IBA
02/2013 - 04/2002
2squamous cell carcinoma-related antigenIBA
11/2010 - 07/2004
2liposomal doxorubicin (Doxil)FDA Link
06/2006 - 09/2004
2Deoxyglucose (2 Deoxy D glucose)IBA
01/2006 - 02/2004
1rucaparibIBA
12/2022
1Choline (Choline Chloride)IBA
10/2021
1olaparibIBA
07/2021
1Fentanyl (Sublimaze)FDA LinkGeneric
01/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1serum P-component (CIt)IBA
01/2018
1Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
01/2017
1somatotropin releasing hormone receptorIBA
01/2017
1Cadherins (E-Cadherin)IBA
01/2017
1Small Interfering RNA (siRNA)IBA
01/2017
1LipidsIBA
01/2017
1Protons (Proton)IBA
01/2017
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2016
1BuffersIBA
10/2015
1GemcitabineFDA Link
06/2015
1MicroRNAs (MicroRNA)IBA
12/2014
1human ERBB2 proteinIBA
09/2014
1ErbB Receptors (EGF Receptor)IBA
09/2014
1Metalloproteases (Metalloproteinases)IBA
09/2014
1Tyrosine Kinase InhibitorsIBA
09/2014
1Lapatinib (GW572016)FDA Link
09/2014
1Tyrosine (L-Tyrosine)FDA Link
09/2014
1N 30IBA
06/2013
1Tumor Biomarkers (Tumor Markers)IBA
06/2013
1Biological ProductsIBA
03/2013
1SteroidsIBA
02/2013
1Estrogens (Estrogen)FDA Link
02/2013
1NucleophosminIBA
02/2013
1AntibodiesIBA
01/2013
1activin receptor type II-A (activin A receptor, type II)IBA
01/2013
1Imiquimod (Aldara)FDA LinkGeneric
12/2012
1Hemoglobins (Hemoglobin)IBA
06/2011
1Keratin-5 (Keratin 5)IBA
11/2008
1Keratins (Keratin)IBA
11/2008
1Calbindin 2IBA
11/2008
1VimentinIBA
11/2008
1Papillomavirus Vaccines (HPV Vaccines)IBA
05/2007

Therapy/Procedure

9Drug Therapy (Chemotherapy)
12/2022 - 03/2005
9Chemoradiotherapy
01/2018 - 09/2004
8Therapeutics
07/2021 - 04/2002
7Salvage Therapy
07/2021 - 02/2004
6Hysterectomy
06/2017 - 04/2002
5Cytoreduction Surgical Procedures
12/2022 - 11/2017
5Adjuvant Chemotherapy
07/2021 - 01/2006
5Radiotherapy
11/2012 - 09/2004
3Hyperthermic Intraperitoneal Chemotherapy
12/2022 - 12/2021
3Laparotomy
01/2021 - 11/2005
2Neoadjuvant Therapy
07/2021 - 06/2017
2Aftercare (After-Treatment)
04/2020 - 06/2014
2Adjuvant Radiotherapy
06/2017 - 10/2012
2Lymph Node Excision (Lymph Node Dissection)
09/2013 - 12/2012
1Pain Management
01/2021
1Patient-Controlled Analgesia (Analgesia, Patient Controlled)
01/2021
1Analgesia
01/2021
1Debridement
04/2015
1Perforator Flap
04/2015
1Immunomodulation
04/2015